-
Mashup Score: 2A roadmap to better health in the USA - 11 hour(s) ago
On Jan 20, 2025, the Trump administration will take charge at a crucial time for health in the USA. To address the seriousness of the task ahead, The Lancet today publishes what can serve as a presidential briefing book, bringing together the best evidence on the state of health in the USA and some solutions for improving it.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 12The Warnock Report: 40 years on - 16 hour(s) ago
Published in 1984, the Warnock Report gave the embryo a “special status”, enabling medical research. As science and society develops, there are new challenges. Jacqui Thornton reports.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Fibrolamellar hepatocellular carcinoma and biopsy-proven right hilar mass and lung nodules - 18 hour(s) ago
A 36-year-old man with a 6-month history of asthenia, impotence, loss of libido, polyuria, and polydipsia attended our department; he also reported needing to wake up twice at night to urinate and Raynaud’s phenomenon. On examination, his weight was 69 kg, height 1·79 m with a BMI of 24·1 kg/m2; the patient stated he had recently lost 5 kg. Significant muscle atrophy and a reduction of body hair was noted. He had lymphadenopathy of cervical and inguinal nodes. Neurological examination was normal—he had
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 46Chronic pancreatitis - 21 hour(s) ago
Chronic pancreatitis is a progressive fibroinflammatory disease primarily caused by a complex interplay of environmental and genetic risk factors. It might result in pancreatic exocrine and endocrine insufficiency, chronic pain, reduced quality of life, and increased mortality. The diagnosis is based on the presence of typical symptoms and multiple morphological manifestations of the pancreas, including pancreatic duct stones and strictures, parenchymal calcifications, and pseudocysts. Management of chronic pancreatitis consists of prevention and treatment of complications, requiring a multidisciplinary approach focusing on lifestyle modifications, exocrine insufficiency, nutritional status, bone health, endocrine insufficiency, pain management, and psychological care.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 254Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment - 22 hour(s) ago
The global epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing worldwide. People with MASLD can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 diabetes, cardiovascular disease, chronic kidney disease, and extrahepatic cancers. Most people with MASLD die from cardiac-related causes. This outcome is attributed to the shared pathogenesis of MASLD and cardiometabolic diseases, involving unhealthy dietary habits, dysfunctional adipose tissue, insulin resistance, and subclinical inflammation.
Source: www.thelancet.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Chronic pancreatitis - 1 day(s) ago
Chronic pancreatitis is a progressive fibroinflammatory disease primarily caused by a complex interplay of environmental and genetic risk factors. It might result in pancreatic exocrine and endocrine insufficiency, chronic pain, reduced quality of life, and increased mortality. The diagnosis is based on the presence of typical symptoms and multiple morphological manifestations of the pancreas, including pancreatic duct stones and strictures, parenchymal calcifications, and pseudocysts. Management of chronic pancreatitis consists of prevention and treatment of complications, requiring a multidisciplinary approach focusing on lifestyle modifications, exocrine insufficiency, nutritional status, bone health, endocrine insufficiency, pain management, and psychological care.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 15Physical findings - 2 day(s) ago
I spent most of my 2010 wedding day in the emergency ward of my local hospital. Instead of exchanging vows, I was desperately trying to convince the doctors there not to call elder protective services regarding the woman who was about to become my mother-in-law. She had been preparing for the marriage of her youngest son for weeks. Between cooking for more than 200 guests, pressing all the wedding finery, and trying to educate the American bride who would be joining her family on Vietnamese traditions, she kept telling us she was “so tired”.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Advances in dementia research and clinical care in 2024 - 2 day(s) ago
Progress in dementia research and clinical care has continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild cognitive impairment or early dementia due to Alzheimer’s disease in multiple countries and regions, including China, Hong Kong, Israel, Japan, Korea, the EU, the United Arab Emirates, and the USA. In the USA, which had the first approvals, approximately 9000 patients are now undergoing treatment with AATs.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5European health security needs a reboot in 2025 - 2 day(s) ago
2025 marks the centenary of the Locarno Treaties—a series of treaties between European countries after World War 1, negotiated in October, 1925, in Locarno, Switzerland, and signed in London in December, 1925. These agreements ushered in a period of hopeful optimism and peace for European security: the so-called Spirit of Locarno. Relations were re-established between European neighbours and Germany was accepted into the League of Nations. The Nobel Peace Prize was awarded to the three main architects of the treaties.
Source: www.thelancet.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 40
In patients with gout initiating urate-lowering therapy, the risk of cardiovascular events was reduced in those prescribed colchicine prophylaxis compared with no prophylaxis. These findings provide an additional argument for using colchicine for gout flare prophylaxis.
Source: www.thelancet.comCategories: General Medicine News, RheumatologyTweet
A roadmap to better #health in the #USA @TheLancet https://t.co/VQNNgyASse